2021 American Transplant Congress » Kidney Immunosuppression: Induction Therapy
Date & Time:
None. Available on demand
Location: Virtual
Session Type: Poster Abstract
Meeting: 2021 American Transplant Congress
-
A Comparative Analysis of Kidney Allograft Outcomes in Steroid Use versus Steroid Discontinuation After Basiliximab Induction: Unos Data Base Study
-
A Question with Multiple Answers: Do Renal Transplant Recipients Require Steroid Maintenance Following Thymoglobulin Induction?
-
Alemtuzumab vs Antithymocyte Globulin Induction in Hepatitis C Viremic Donors to Hepatis C Negative Kidney Transplant Recipients
-
Cost Savings Initiative with Idea Body Weight Dosing of Rabbit Anti-thymocyte Globulin (rATG) Induction in an Older Kidney Transplant Population: A Single Center Analysis
-
Outcomes in Standard vs. Extended Use of Thymoglobulin as Induction Therapy in Kidney Transplant Recipients
-
Outcomes of Second Kidney Transplant After Return to Dialysis by Induction Type in the United States
-
Preemptive Second Kidney Transplant Outcomes by Induction Type in the United States
-
Rabbit Anti-thymocyte Globulin Induction Dosing Strategies in a High-risk Kidney Transplant Population
-
Sirolimus (srl) versus Everolimus (evr) versus Mycophenolate (mpa) in Kidney Transplant Recipients Receiving Anti-thymocyte Globulin Induction (r-atg), Tacrolimus (tac), and Prednisone
-
The Impact of Fixed-Dose Alemtuzumab in Renal Transplant Recipients According to Weight
« View all sessions from the 2021 American Transplant Congress